Drug Utilization Evaluation of Chemotherapy on Colorectal Cancer Patients in Taiwan
碩士 === 高雄醫學大學 === 臨床藥學研究所 === 99 === BACKGROUND: Colorectal Cancer (CRC) is the third leading cause of cancer death in Taiwan. Surgery and auxiliary chemotherapy are common treatment strategies for this disease. Target therapies which have shown benefits in clinical trials have arrived on the market...
Main Authors: | Yi-Hau Lin, 林義豪 |
---|---|
Other Authors: | Yaw-bin Huang |
Format: | Others |
Language: | zh-TW |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/00792532950210698025 |
Similar Items
-
The Outcome and Resource Utilization of Surgery for the new case of Colorectal Cancer Patients in Taiwan
by: Ying-Chung Lin, et al.
Published: (2010) -
The Compliance to Oral Chemotherapy in Colorectal Cancer Patients
by: Anna Hu, et al.
Published: (2004) -
Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
by: Bengt Glimelius, et al.
Published: (2020-08-01) -
Inequality in Colorectal Cancer Drug Utilization:Formulary Coverage of the National Health Insurance in Taiwan
by: Chin-wen Cheng, et al.
Published: (2010) -
Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
by: Lisi Zeng, et al.
Published: (2021-08-01)